Identification of achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours

BMC Cancer

Volumn 9, Issue , 2009, Pages 321-

  Johansson, Térèse A ^a   Westin, Gunnar ^a   Skogseid, Britt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR MASH1; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; PANCREAS ISLET CELL TUMOR; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 70349873222     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-321     Document Type: Article

References (25)

1. Huber K, Bruhl B, Guillemot F, Olson EN, Ernsberger U, Unsicker K. Development of chromaffin cells depends on MASH1 function. Development 2002, 129:4729-4738.
2. Lanigan TM, DeRaad SK, Russo AF. Requirement of the MASH-1 transcription factor for neuroendocrine differentiation of thyroid C cells. J Neurobiol 1998, 34:126-134. 10.1002/(SICI)1097-4695(19980205)34:2<126::AID-NEU3>3.0.CO;2-4, 9468384.
3. Borges M, Linnoila RI, Velde HJ, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 1997, 386:852-855. 10.1038/386852a0, 9126746.
4. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H. Notch signalling controls pancreatic cell differentiation. Nature 1999, 400:877-881. 10.1038/23716, 10476967.
5. Murtaugh LC, Stanger BZ, Kwan KM, Melton DA. Notch signalling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci USA 2003, 100:14920-14925. 10.1073/pnas.2436557100, 299853, 14657333.
6. Esni F, Ghosh B, Biankin AV, Lin JW, Albert MA, Yu X, MacDonald RJ, Civin CI, Real FX, Pack MA, Ball DW, Leach SD. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 2004, 131:4213-4224. 10.1242/dev.01280, 15280211.
7. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signalling pathway. J Cell Physiol 2003, 194:237-255. 10.1002/jcp.10208, 12548545.
8. Johansson T, Lejonklou MH, Ekeblad S, Stålberg P, Skogseid B. Lack of Nuclear Expression of Hairy and Enhancer of Split-1 (HES1) in Pancreatic Endocrine Tumours. Horm Metab Res 2008, 40:354-359. 10.1055/s-2008-1076695, 18491256.
9. Osada H, Tomida S, Yatabe Y, Tatematsu Y, Takeuchi T, Murakami H, Kondo Y, Sekido Y, Takahashi T. Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 2008, 68:1647-1655. 10.1158/0008-5472.CAN-07-5039, 18339843.
10. Wells JM, Esni F, Boivin GP, Aronow BJ, Stuart W, Combs C, Sklenka A, Leach SD, Lowy AM. Wnt/beta-catenin signalling is required for development of the exocrine pancreas. BMC Dev Biol 2007, 7:4. 10.1186/1471-213X-7-4, 1783845, 17222338.
11. Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X, Taketo MM, Nusse R, Hebrok M, Kim SK. Wnt signalling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA 2007, 104:6247-6252. 10.1073/pnas.0701509104, 1847455,1847455, 17404238.
12. Nakakura EK, Sriuranpong VR, Kunnimalaiyaan M, Hsiao EC, Schuebel KE, Borges MW, Jin N, Collins BJ, Nelkin BD, Chen H, Ball DW. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumour cells by notch signalling. J Clin Endocrinol Metab 2005, 90:4350-4356. 10.1210/jc.2005-0540, 15870121.
13. Parekh D, Ishizuka J, Townsend CM, Haber B, Beauchamp RD, Karp G, Kim SW, Rajaraman S, Greeley G, Thompson JC. Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas 1994, 9:83-90. 10.1097/00006676-199401000-00013, 8108375.
14. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264. 10.1093/biostatistics/4.2.249, 12925520.
15. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001, 98:31-36. 10.1073/pnas.011404098, 14539, 11134512.
16. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:Article 3.
17. Wettenhall JM, Smyth GK. LimmaGUI: a graphical user interface for linear modelling of microarray data. Bioinformatics 2004, 20:3705-3706. 10.1093/bioinformatics/bth449, 15297296.
18. Hochberg Y, Ba Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995, 57:289-300.
19. Kunisch M, Haenlin M, Campos-Ortega JA. Lateral inhibition mediated by the Drosophila neurogenic gene delta is enhanced by proneural proteins. Proc Natl Acad Sci USA 1994, 91:10139-10143. 10.1073/pnas.91.21.10139, 44973, 7937851.
20. Castro DS, Skowronska-Krawczyk D, Armant O, Donaldson IJ, Parras C, Hunt C, Critchley JA, Nguyen L, Gossler A, Göttgens B, Matter JM, Guillemot F. Proneural bHLH and Brn proteins coregulate a neurogenic program through cooperative binding to a conserved DNA motif. Dev Cell 2006, 11:831-844. 10.1016/j.devcel.2006.10.006, 17141158.
21. Johnson JE, Birren SJ, Saito T, Anderson DJ. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer. Proc Natl Acad Sci USA 1992, 89:3596-3600. 10.1073/pnas.89.8.3596, 48915, 1314394.
22. Persson P, Jogi A, Grynfeld A, Pahlman S, Axelson H. HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. Biochem Biophys Res Commun 2000, 274:22-31. 10.1006/bbrc.2000.3090, 10903890.
23. Forget MA, Turcotte S, Beauseigle D, Godin-Ethier J, Pelletier S, Martin J, Tanguay S, Lapointe R. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Can 2007, 96:646-653.
24. González-Sancho JM, Aguilera O, García JM, Pendás-Franco N, Peña C, Cal S, García de Herreros A, Bonilla F, Muñoz A. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is down regulated in human colon cancer. Oncogene 2005, 24:1098-1103. 10.1038/sj.onc.1208303, 15592505.
25. Voorzanger-Rousselot N, Goehrig D, Journe F, Doriath V, Body JJ, Clézardin P, Garnero P. Increased Dickkopf-1 expression in breast cancer bone metastases. Br J Cancer 2007, 97:964-970. 2360424, 17876334.